RTW Investments
RTWFF
Performance
About RTW Investments
RTW Investments is a life sciences investment firm based in New York, with additional offices in London and Shanghai. The firm focuses on investing throughout the entire lifecycle of companies, from creation and early stage venture capital to alternative financing and investments in public companies.
Recent News
Kailera Therapeutics' $625 Million IPO Sets Record as Largest Biotech Offering
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
InMed‑Mentari All‑Stock Merger Sends Shares Up 160% and Triggers $290 Million Private Placement
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
Corxel Draws $287M Round to Drive Global Development of Oral GLP-1
Recent Deals
Kailera Raises $1bn in Growth-Stage Funding Round
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
Corxel Secures $287M Series D1 Funding to Advance Oral GLP-1 Obesity Pill
Candel Therapeutics Secures $100M Royalty Funding From RTW Investments
Prolium Bioscience Raises $50M in Series A Backed by RTW Investments